UroGen Pharma (URGN) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for UroGen Pharma (URGN) over the last 10 years, with Q3 2025 value amounting to -$183000.0.
- UroGen Pharma's Other Gross PP&E Adjustments fell 10485.54% to -$183000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183000.0, marking a year-over-year decrease of 10485.54%. This contributed to the annual value of -$9.8 million for FY2024, which is 898.36% down from last year.
- Latest data reveals that UroGen Pharma reported Other Gross PP&E Adjustments of -$183000.0 as of Q3 2025, which was down 10485.54% from $780000.0 recorded in Q2 2025.
- In the past 5 years, UroGen Pharma's Other Gross PP&E Adjustments ranged from a high of $3.8 million in Q3 2024 and a low of -$9.8 million during Q4 2024
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $2.1 million (2021), whereas its average is -$138578.9.
- In the last 5 years, UroGen Pharma's Other Gross PP&E Adjustments soared by 60686.81% in 2021 and then crashed by 10485.54% in 2025.
- Over the past 5 years, UroGen Pharma's Other Gross PP&E Adjustments (Quarter) stood at -$7.9 million in 2021, then fell by 19.45% to -$9.5 million in 2022, then increased by 5.34% to -$9.0 million in 2023, then decreased by 8.98% to -$9.8 million in 2024, then surged by 98.13% to -$183000.0 in 2025.
- Its Other Gross PP&E Adjustments stands at -$183000.0 for Q3 2025, versus $780000.0 for Q2 2025 and $868000.0 for Q1 2025.